Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodies. NICE technology appraisal guidance 1073

National Institute for Health and Care Excellence (NICE)
Record ID 32018014308
English
Details
Project Status: Completed
URL for project: https://www.nice.org.uk/guidance/ta1073
Year Published: 2025
URL for published report: https://www.nice.org.uk/guidance/ta1073
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England
MeSH Terms
  • Hemophilia A
  • Hemophilia B
  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Humanized
Contact
Organisation Name: National Institute for Health and Care Excellence
Contact Address: 3rd floor, 3 Piccadilly Place, Manchester, M1 3BN
Contact Name: nice@nice.nhs.uk
Contact Email: nice@nice.nhs.uk
Copyright: National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.